The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $77.44

Today's change-2.16 -2.71%
Updated September 21 1:59 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $77.44

Today's change-2.16 -2.71%
Updated September 21 1:59 PM EDT. Delayed by at least 15 minutes.

ResMed Inc crosses below 20-day moving average

ResMed Inc is sharply lower today, dropping (U.S.)$2.16 or 2.71% to (U.S.)$77.44 and crossing below its 20-day moving average. Shares have lost 3.86% over the last five days, but have gained 24.80% over the last year to date. This security has outperformed the S&P 500 by 5.59% during the last year.

Key company metrics

  • Open(U.S.) $78.50
  • Previous close(U.S.) $79.60
  • High(U.S.) $78.75
  • Low(U.S.) $77.44
  • Bid / Ask(U.S.) $77.41 / (U.S.) $77.47
  • YTD % change+24.80%
  • Volume280,972
  • Average volume (10-day)641,382
  • Average volume (1-month)566,055
  • Average volume (3-month)1,049,676
  • 52-week range(U.S.) $56.59 to (U.S.) $81.87
  • Beta0.78
  • Trailing P/E32.23×
  • P/E 1 year forward26.29×
  • Forward PEG2.59×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield1.81%
  • Trailing EPS(U.S.) $2.40
Updated September 21 1:59 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.54%Sector:HealthcareIndustry:Advanced Medical Equipment

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2017Q3/2017Q2/2017Q1/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue557514530465
Total other revenue--------
Total revenue557514530465
Gross profit324300309269
Total cost of revenue233214221196
Total operating expense429407434371
Selling / general / administrative148138139129
Research & development37353834
Depreciation / amortization12111212
Interest expense (income), net operating--------
Unusual expense (income)0823--
Other operating expenses, total--------
Operating income1271079794
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1221089693
Income after tax102887776
Income tax, total20201917
Net income102887776
Total adjustments to net income--------
Net income before extra. items102887776
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items102887776
Inc. avail. to common incl. extra. items102887776
Diluted net income102887776
Dilution adjustment------0
Diluted weighted average shares143143142142
Diluted EPS excluding extraordinary itemsvalue per share0.710.620.540.54
Dividends per sharevalue per share0.330.330.330.33
Diluted normalized EPSvalue per share0.710.660.670.54